Bioform Medical falls in market debut
NEW YORK, Nov 7 (Reuters) - Shares of Bioform Medical Inc (BFRM.O: Quote, Profile, Research, Stock Buzz) fell in their market debut on Wednesday, a day after an initial public offering that priced below a forecast range.
Shares fell 3.5 percent to $7.72 per share in early trading.
On Tuesday, Bioform's 10-million share offering priced at $8 per share, compared with a forecast range of $9 to $11.
The San Mateo, California-based firm focuses on developing and commercializing products used by plastic surgeons to enhance appearance.
Underwriters, led by JPMorgan Chase (JPM.N: Quote, Profile, Research, Stock Buzz), have the option to purchase an additional 750,000 shares to cover overallotments. (Reporting by Lilla Zuill, Editing by Gerald E. McCormick)
© Thomson Reuters 2008 All rights reserved
Help us advance this story. Provide relevant links or share your insights using our comment box. Please be considerate and help us by reporting any abuse you find. Reuters will delete comments that don't meet community standards.
Have a correction to this article? Email the editors
Tighter race?
Asia greets G7 weekend pledges